Naoyoshi Terakawa

Summary

Affiliation: Kansai Medical University
Country: Japan

Publications

  1. ncbi Surgical influence of pancreatectomy on the function and count of circulating dendritic cells in patients with pancreatic cancer
    Kanji Takahashi
    Department of Surgery, Kansai Medical University, 10-15, Fumizono, Moriguchi, 570-8507, Japan
    Cancer Immunol Immunother 55:775-84. 2006
  2. ncbi Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial
    Naoyoshi Terakawa
    Department of Surgery, Kansai Medical University, Osaka, Japan
    Nutr Cancer 60:643-51. 2008
  3. ncbi Circulating dendritic cells and development of septic complications after pancreatectomy for pancreatic cancer
    Kanji Takahashi
    Department of Surgery, Kansai Medical University, 2 3 1, Shin Machi, Hirakata, Osaka, 573 1191, Japan
    Arch Surg 142:1151-7; discussion 1157. 2007
  4. ncbi Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer
    Soichiro Takai
    Department of Surgery, Kansai Medical University, Hirakata City, Osaka, Japan
    Pancreas 36:e26-32. 2008
  5. ncbi Circulating myeloid dendritic cells as prognostic factors in patients with pancreatic cancer who have undergone surgical resection
    Tomohisa Yamamoto
    Department of Surgery, Kansai Medical University, Osaka, Japan
    J Surg Res 173:299-308. 2012
  6. ncbi Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection
    Yoichi Matsui
    Department of Surgery, Kansai Medical University, 2 3 1 Shinmachi, Hirakata, Osaka 573 1191, Japan
    Arch Surg 142:596-602; discussion 603. 2007
  7. ncbi Less morbidity after pancreaticoduodenectomy of patients with pancreatic cancer
    Sohei Satoi
    Department of Surgery, Kansai Medical University, Osaka, Japan
    Pancreas 33:45-52. 2006
  8. ncbi Clinical monitoring of innate cellular immunity of monocytes/macrophages by tumor necrosis factor alpha productivity in whole blood stimulated by lipopolysaccharide in patients with pancreatic cancer
    Naoyoshi Terakawa
    Departments of Surgery, Kansai Medical University, Osaka, Japan
    Pancreas 33:31-7. 2006
  9. ncbi Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer
    Hiroaki Yanagimoto
    Department of Surgery, Kansai Medical University, 2 3 1 Shinmachi, Hirakata, Osaka 573 1191, Japan
    Cancer Sci 98:605-11. 2007
  10. ncbi Impaired function of circulating dendritic cells in patients with pancreatic cancer
    Hiroaki Yanagimoto
    Department of Surgery, Kansai Medical University, Osaka, Japan
    Clin Immunol 114:52-60. 2005

Collaborators

Detail Information

Publications10

  1. ncbi Surgical influence of pancreatectomy on the function and count of circulating dendritic cells in patients with pancreatic cancer
    Kanji Takahashi
    Department of Surgery, Kansai Medical University, 10-15, Fumizono, Moriguchi, 570-8507, Japan
    Cancer Immunol Immunother 55:775-84. 2006
    ..When a patient remained disease free, the recovery of cDC1 counts was observed approximately 12 months after pancreatectomy. Further strategy will be needed to improve immune function in patients with pancreatic cancer...
  2. ncbi Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial
    Naoyoshi Terakawa
    Department of Surgery, Kansai Medical University, Osaka, Japan
    Nutr Cancer 60:643-51. 2008
    ..No significant differences in PHA, NK cell activity, and cytokine production were found between groups. AHCC intake resulted in the increased number of DCs and function of DC1s, which have a role in specific immunity...
  3. ncbi Circulating dendritic cells and development of septic complications after pancreatectomy for pancreatic cancer
    Kanji Takahashi
    Department of Surgery, Kansai Medical University, 2 3 1, Shin Machi, Hirakata, Osaka, 573 1191, Japan
    Arch Surg 142:1151-7; discussion 1157. 2007
    ..To investigate whether circulating dendritic cells in patients with pancreatic cancer is a risk factor for septic complications after pancreatectomy...
  4. ncbi Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer
    Soichiro Takai
    Department of Surgery, Kansai Medical University, Hirakata City, Osaka, Japan
    Pancreas 36:e26-32. 2008
    ....
  5. ncbi Circulating myeloid dendritic cells as prognostic factors in patients with pancreatic cancer who have undergone surgical resection
    Tomohisa Yamamoto
    Department of Surgery, Kansai Medical University, Osaka, Japan
    J Surg Res 173:299-308. 2012
    ..We aimed to determine the influence on survival of circulating myeloid dendritic cells (c-m-DCs), circulating lymphoid DCs (c-l-DCs), and DCs within the tumor tissue in patients with pancreatic cancer...
  6. ncbi Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection
    Yoichi Matsui
    Department of Surgery, Kansai Medical University, 2 3 1 Shinmachi, Hirakata, Osaka 573 1191, Japan
    Arch Surg 142:596-602; discussion 603. 2007
    ..We hypothesized that no-margin resections for hepatocellular carcinoma do not negatively affect patient outcomes...
  7. ncbi Less morbidity after pancreaticoduodenectomy of patients with pancreatic cancer
    Sohei Satoi
    Department of Surgery, Kansai Medical University, Osaka, Japan
    Pancreas 33:45-52. 2006
    ..One result of this additional surgical stress may be that postoperative complications in patients with pancreatic cancer are more frequent than in patients with periampullary cancer...
  8. ncbi Clinical monitoring of innate cellular immunity of monocytes/macrophages by tumor necrosis factor alpha productivity in whole blood stimulated by lipopolysaccharide in patients with pancreatic cancer
    Naoyoshi Terakawa
    Departments of Surgery, Kansai Medical University, Osaka, Japan
    Pancreas 33:31-7. 2006
    ..A method of assessing the capability of leukocytes, particularly macrophages, to produce TNF-alpha could be useful for prognostis and for monitoring immunocompetence in patients with pancreatic cancer who have undergone chemotherapy...
  9. ncbi Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer
    Hiroaki Yanagimoto
    Department of Surgery, Kansai Medical University, 2 3 1 Shinmachi, Hirakata, Osaka 573 1191, Japan
    Cancer Sci 98:605-11. 2007
    ..GEM did not inhibit the immune responses induced by personalized peptide vaccinations, and this new type of immunochemotherapy combination is recommended for further clinical study in APC patients...
  10. ncbi Impaired function of circulating dendritic cells in patients with pancreatic cancer
    Hiroaki Yanagimoto
    Department of Surgery, Kansai Medical University, Osaka, Japan
    Clin Immunol 114:52-60. 2005
    ..DCs were tested for the ability to stimulate allogeneic T lymphocytes in mixed leukocyte reaction (MLR). CD4/8, NK activity, PHA, and TGF-beta1 were also measured...